KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vir Biotechnology (VIR) Shares Outstanding (Weighted Average) (2018 - 2025)

Historic Shares Outstanding (Weighted Average) for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to $138.9 million.

  • Vir Biotechnology's Shares Outstanding (Weighted Average) rose 166.58% to $138.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $138.9 million, marking a year-over-year increase of 166.58%. This contributed to the annual value of $136.2 million for FY2024, which is 157.75% up from last year.
  • According to the latest figures from Q3 2025, Vir Biotechnology's Shares Outstanding (Weighted Average) is $138.9 million, which was up 166.58% from $138.4 million recorded in Q2 2025.
  • In the past 5 years, Vir Biotechnology's Shares Outstanding (Weighted Average) registered a high of $138.9 million during Q3 2025, and its lowest value of $127.7 million during Q1 2021.
  • For the 5-year period, Vir Biotechnology's Shares Outstanding (Weighted Average) averaged around $134.4 million, with its median value being $134.2 million (2023).
  • As far as peak fluctuations go, Vir Biotechnology's Shares Outstanding (Weighted Average) soared by 1785.69% in 2021, and later soared by 114.94% in 2023.
  • Vir Biotechnology's Shares Outstanding (Weighted Average) (Quarter) stood at $129.9 million in 2021, then grew by 2.1% to $132.6 million in 2022, then increased by 1.15% to $134.1 million in 2023, then grew by 1.58% to $136.2 million in 2024, then rose by 1.97% to $138.9 million in 2025.
  • Its last three reported values are $138.9 million in Q3 2025, $138.4 million for Q2 2025, and $137.5 million during Q1 2025.